Rivastigmine
NDC 70771-1951, Rivastigmine, patch, extended release, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1951
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206318
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE13.3 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1951-7 | 70771195107 | 30 POUCH in 1 CARTON (70771-1951-7) / 24 h in 1 POUCH (70771-1951-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/966d59ea-5cea-4fef-8b96-e0efe885caf4
Use it
Look up 70771-1951 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1951 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1951. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.